Physician profile
Summer Bell
NPI 1154031292
$16,255.95
in general payments reported to CMS, 2019-2025
7 companies · $3,427 in 2025
The $3,427 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $123 · 2024: $13K · 2025: $3,427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Travel and Lodging: $3,575 · Food and Beverage: $755 · Consulting Fee: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,520.00 |
| Travel and Lodging | $3,575.46 |
| Food and Beverage | $755.49 |
| Consulting Fee | $405.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tg Therapeutics, INC. | $15,994.71 | 2024-2025 | |
| Horizon Therapeutics Plc | $101.03 | 2023 | Uplizna |
| Amgen INC. | $74.21 | 2024 | Evenity |
| Grifols USA, LLC | $26.02 | 2024 | Gamunex-C |
| Alexion Pharmaceuticals, INC. | $24.39 | 2024 | Ultomiris |
| Astrazeneca Pharmaceuticals LP | $21.75 | 2023 | Fasenra |
| Lilly USA, LLC | $13.84 | 2024 | Omvoh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Summer Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.